Ionis Pharmaceuticals announced the appointment of a new member to its board of directors effective immediately – Joan E. Herman, MBA, MS, president and chief executive officer of Herman and Associates.
Halozyme Therapeutics announced the appointment of Bernadette Connaughton to its board of directors. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the board.